Clinical trial
Exploratory Clinical Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors
NCT06431529 is registered in ClinicalTrials.gov with JIANG LONGWEI as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Clinical Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors
- Lead sponsor
- JIANG LONGWEI
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- April 18, 2024
- Completion date
- December 31, 2025
- Enrollment
- 6 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tumor, solid